Patent · US Active

Tissue conduction communication (TCC) transmission

US9636511B2 · kind B2 · utility

80Cited by
24References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 23, 2015
Grant dateMay 2, 2017
Priority date
Expiry dateJul 11, 2035

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61N1/05
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

An implantable cardioverter defibrillator (ICD) configured to transmit a tissue conduction communication (TCC) signal includes a TCC transmitter module configured to generate the TCC signal and transmit the TCC signal via a plurality of electrodes. The TCC signal comprises a biphasic signal having an amplitude and a frequency, wherein at least one of the amplitude and the frequency are configured to avoid stimulation of tissue of the patient. The TCC transmitter module comprises protection circuitry coupled between a current source and the plurality of electrodes, wherein the protection circuitry is configured to protect the signal generator from an external anti-tachyarrhythmia shock delivered to the patient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.